We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immune Abnormalities Meet Diagnostic Criteria for Myalgic Encephalomyelitis

By LabMedica International staff writers
Posted on 16 Jan 2014
Print article
Image: FACSCalibur flow cytometer (Photo courtesy of Becton Dickinson).
Image: FACSCalibur flow cytometer (Photo courtesy of Becton Dickinson).
Immunological abnormalities have been identified in Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS) patients and significant developments have been made to the diagnostic criteria

Potential immunological markers have not been assessed in patients fulfilling these latest clinical requirements and therefore there is a need to evaluate immunological parameters in patients that also fulfill the latest diagnostic criteria available known as the International Consensus Criteria (ICC).

Immunologists at Griffith University (Gold Coast, Australia) recruited 63 participants of which 41 were ME/CFS patients and 22 were healthy controls. Whole blood samples were collected from all participants. With the exception of Natural Killer (NK) cell phenotyping experiments, whole blood was used for all phenotyping studies.

For all flow cytometer experiments, the monoclonal antibodies were fluorescently labeled with fluorescein isothiocyanate, phycoerythrin, allophycocyanin and peridinin chlorophyll, and analysis was performed on a four-color flow cytometer. The activity of NK cells was measured using a well-known flow cytometric method stained with annexin V and 7-AAD (Becton Dickinson (BD); San Diego, CA, USA) and analyzed on the BD fluorescence-activated cell sorting (FACS) Calibur flow cytometer.

In patients with ME/CFS, NK cell activity was significantly reduced in comparison to healthy controls. Measures of NK cell lytic proteins did not yield any significance difference between the groups. A significant increase in regulatory T-cells (Tregs) was observed ME/CFS patients in comparison to healthy controls. A significant decrease in cluster of differentiation CD39+ Tregs was observed in one group of ME/CFS patients in comparison to healthy controls. No significant differences were observed in B-cells, NK cells and plasmacytoid and myeloid (DC) phenotypes.

The authors concluded that differences could be found in human neutrophil antigens and expression of natural killer cell receptors between patient groups. Highly significant correlations were also found between physical status and some immune parameters in ICC defined patients. This preliminary investigation on different diagnostic criteria suggests that the ICC may be more effective in detecting salient differences in the immune system. The study was published on November 14, 2013, in the Journal of Molecular Biomarkers & Diagnosis.

Related Links:

Griffith University
Becton Dickinson 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: ColoSense is the first FDA-approved RNA-based molecular screening test for qualitative detection of colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer

Colorectal cancer (CRC) ranks as the second most lethal cancer in the United States. Nevertheless, many Americans eligible for screening do not undergo testing due to limited access or reluctance towards... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more